Depression Case Control (DeCC) Study fails to support involvement of the muscarinic acetylcholine receptor M2 (CHRM2) gene in recurrent major depressive disorder.
paper
Cited
Public
Unavailable
- Authors
- Cohen-Woods, Sarah; Gaysina, Daria; Craddock, Nick; Farmer, Anne; Gray, Joanna; Gunasinghe, Cerisse; Hoda, Farzana; Jones, Lisa; Knight, Jo; Korszun, Ania; Owen, Michael J; Sterne, Abram; Craig, Ian W; McGuffin, Peter
- Year
- 2009
- Journal
- Human molecular genetics
- PMID
- 19181679
- DOI
- 10.1093/hmg/ddp051
It has been suggested that alteration in the muscarinic-cholinergic system is involved in modulation of mood. Three studies have reported linkage on chromosome 7 with major depressive disorder (MDD) in or close to a region containing the muscarinic receptor CHRM2 gene. A haplotype of SNPs located in CHRM2 (rs1824024-rs2061174-rs324650) has been significantly associated with MDD in a previous study. We report the first study investigating this gene in a large, adequately powered, clinical depression case-control sample (n = 1420 cases, 1624 controls). Our data fail to support association with the CHRM2 polymorphisms previously implicated in the genetic aetiology of depression. It is possible our failure to replicate may be a consequence of differences in definition of the MDD phenotype and/or ethnic differences.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Influence of BDNF Val66Met genetic polymorphism in Major Depressive Disorder and Body Mass Index: Evidence from a meta-analysis of 6481 individuals. | PΓ©rez-GutiΓ©rrez AM et al. | β | 2024 | β |
| Whole blood mitochondrial copy number in clinical populations with mood disorders: A meta-analysis: Blood mitochondrial copy number and mood disorders. | Calarco CA et al. | β | 2024 | β |
| Whole blood mitochondrial copy number in clinical populations with mood disorders: a meta-analysis | Calarco CA et al. | β | 2023 | β |
| Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders. | Johnson CR et al. | β | 2022 | β |
| Genome-wide association study of suicidal behaviour severity in mood disorders. | Zai CC et al. | β | 2021 | β |
| Cell-Type-Specific Proteogenomic Signal Diffusion for Integrating Multi-Omics Data Predicts Novel Schizophrenia Risk Genes. | Torshizi AD et al. | β | 2020 | β |
| Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of <i>CHRM1</i> and <i>CHRM2</i> muscarinic receptors. | Boiko AS et al. | β | 2020 | β |
| Polygenic risk for circulating reproductive hormone levels and their influence on hippocampal volume and depression susceptibility. | Smeeth DM et al. | β | 2019 | β |
| Collaborative meta-analysis finds no evidence of a strong interaction between stress and 5-HTTLPR genotype contributing to the development of depression. | Culverhouse RC et al. | β | 2018 | β |
| Unravelling the GSK3Ξ²-related genotypic interaction network influencing hippocampal volume in recurrent major depressive disorder. | Inkster B et al. | β | 2018 | β |
| Genetic predisposition to advanced biological ageing increases risk for childhood-onset recurrent major depressive disorder in a large UK sample. | Michalek JE et al. | β | 2017 | β |
| Interaction between the <i>FTO</i> gene, body mass index and depression: meta-analysis of 13701 individuals. | Rivera M et al. | β | 2017 | β |
| Polygenic Scores for Major Depressive Disorder and Risk of Alcohol Dependence. | Andersen AM et al. | β | 2017 | β |
| Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments. | Sakata K et al. | β | 2017 | β |
| Polygenic interactions with environmental adversity in the aetiology of major depressive disorder. | Mullins N et al. | β | 2016 | β |
| A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder. | Hung CF et al. | β | 2015 | β |
| Elevated Hippocampal Cholinergic Neurostimulating Peptide precursor protein (HCNP-pp) mRNA in the amygdala in major depression. | Bassi S et al. | β | 2015 | β |
| Familiality and SNP heritability of age at onset and episodicity in major depressive disorder. | Ferentinos P et al. | β | 2015 | β |
| Measuring Life Events and Their Association With Clinical Disorder: A Protocol for Development of an Online Approach. | Spence R et al. | β | 2015 | β |
| Modulatory effects of brain-derived neurotrophic factor Val66Met polymorphism on prefrontal regions in major depressive disorder. | Legge RM et al. | β | 2015 | β |
| Molecular signatures of major depression. | Cai N et al. | β | 2015 | β |
| The Role of Muscarinic Receptors in the Pathophysiology of Mood Disorders: A Potential Novel Treatment? | Jeon WJ et al. | β | 2015 | β |
| The similarity of the structure of DSM-IV criteria for major depression in depressed women from China, the United States and Europe. | Kendler KS et al. | β | 2015 | β |
| CHRM2 but not CHRM1 or CHRM3 polymorphisms are associated with asthma susceptibility in Mexican patients. | JimΓ©nez-Morales S et al. | β | 2014 | β |
| Genetic relationships between suicide attempts, suicidal ideation and major psychiatric disorders: a genome-wide association and polygenic scoring study. | Mullins N et al. | β | 2014 | β |
| Genetic risk score analysis indicates migraine with and without comorbid depression are genetically different disorders. | Ligthart L et al. | β | 2014 | β |
| Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution. | Ferentinos P et al. | β | 2014 | β |
| Mood disorders and parity - a clue to the aetiology of the postpartum trigger. | Di Florio A et al. | β | 2014 | β |
| Relationship between obesity and the risk of clinically significant depression: Mendelian randomisation study. | Hung CF et al. | β | 2014 | β |
| Therapygenetics in mindfulness-based cognitive therapy: do genes have an impact on therapy-induced change in real-life positive affective experiences? | Bakker JM et al. | β | 2014 | β |
| Assessment of genetic and nongenetic interactions for the prediction of depressive symptomatology: an analysis of the Wisconsin Longitudinal Study using machine learning algorithms. | Roetker NS et al. | β | 2013 | β |
| Estimating the heritability of reporting stressful life events captured by common genetic variants. | Power RA et al. | β | 2013 | β |
| Interaction between specific forms of childhood maltreatment and the serotonin transporter gene (5-HTT) in recurrent depressive disorder. | Fisher HL et al. | β | 2013 | β |
| Modulation of amygdala response and connectivity in depression by serotonin transporter polymorphism and diagnosis. | Costafreda SG et al. | β | 2013 | β |
| The interaction between child maltreatment, adult stressful life events and the 5-HTTLPR in major depression. | Power RA et al. | β | 2013 | β |
| Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. | Joeyen-Waldorf J et al. | β | 2012 | β |
| Depressive disorder moderates the effect of the FTO gene on body mass index. | Rivera M et al. | β | 2012 | β |
| Genome-wide association study of comorbid depressive syndrome and alcohol dependence. | Edwards AC et al. | β | 2012 | β |
| Life-event specificity: bipolar disorder compared with unipolar depression. | Hosang GM et al. | β | 2012 | β |
| Muscarinic receptors: their roles in disorders of the central nervous system and potential as therapeutic targets. | Scarr E | β | 2012 | β |
| Polymorphisms in human muscarinic receptor subtype genes. | Michel MC et al. | β | 2012 | β |
| Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression. | Fisher HL et al. | β | 2012 | β |
| White matter abnormalities and illness severity in major depressive disorder. | Cole J et al. | β | 2012 | β |
| Genetic variation in cholinergic muscarinic-2 receptor gene modulates M2 receptor binding in vivo and accounts for reduced binding in bipolar disorder. | Cannon DM et al. | β | 2011 | β |
| Genomewide association scan of suicidal thoughts and behaviour in major depression. | Schosser A et al. | β | 2011 | β |
| No effect of 5HTTLPR or BDNF Val66Met polymorphism on hippocampal morphology in major depression. | Cole J et al. | β | 2011 | β |
| Association of existing and new candidate genes for anxiety, depression and personality traits in older people. | Luciano M et al. | β | 2010 | β |
| Genome-wide association study of major recurrent depression in the U.K. population. | Lewis CM et al. | β | 2010 | β |
| Lack of association of a spontaneous mutation of the Chrm2 gene with behavioral and physiologic phenotypic differences in inbred mice. | Ding M et al. | β | 2010 | β |
| Striatal structure and function in mood disorders: a comprehensive review. | Marchand WR et al. | β | 2010 | β |